In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Guilhem RoyerUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0000-0001-9092-8336 Maxime DanjeanEquipe Opérationnelle d'Hygiène, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0009-0009-7633-8167 Vincent FihmanUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0000-0001-9327-7524 Emmanuelle GalloisUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.
Eve TessierUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.
Florence ReibelUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.
Nicolas CabanelEcology and Evolution of Antibiotic Resistance Unit, Institut Pasteur, CNRS UMR6047, Université Paris Cité, , Paris, France.
Philippe GlaserEcology and Evolution of Antibiotic Resistance Unit, Institut Pasteur, CNRS UMR6047, Université Paris Cité, , Paris, France.
Paul-Louis WoertherUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0000-0002-6957-9482 Hervé JacquierUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0000-0002-6323-5910 Funding
Agence Nationale de la Recherche ANR-20-PAMR-0010
6 · The paper itselfAbstract
Piperacillin-tazobactam (TZP) resistance in
Indexed as
Anti-Bacterial Agentsbeta-LactamasesKlebsiella pneumoniaePiperacillin, Tazobactam Drug CombinationPlasmidsBacterial ProteinsDNA Transposable ElementsDrug Resistance, Multiple, BacterialExtrachromosomal DNAHumansKlebsiella InfectionsMicrobial Sensitivity TestsThird Generation CephalosporinsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDNA Transposable ElementsExtrachromosomal DNAPiperacillin, Tazobactam Drug CombinationThird Generation Cephalosporinsgene amplificationgene dosage effectplasmid outbreak
Identifiers
PMID41874364
PMCPMC13148056
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390